Want to see KR:293480 full AI Analyst Report?
Hana Pharm Co., Ltd. (293480) Income Statement
Hana Pharm Co., Ltd. Income Statement
Last quarter (Q2 2026), Hana Pharm Co., Ltd.'s total revenue was $60.90B, an increase of 5.23% from the same quarter last year. In Q2, Hana Pharm Co., Ltd.'s net income was $8.45B. See Hana Pharm Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 239.50B | $ 225.34B | $ 224.46B | $ 210.84B | $ 196.41B | |
| $ 146.39B | $ 141.29B | $ 139.58B | $ 131.24B | $ 130.82B | |
| $ 120.47B | $ 116.14B | $ 112.55B | $ 100.07B | $ 94.81B | |
| Depreciation and Amortization | $ 11.03B | $ 7.72B | $ 7.65B | $ 6.49B | $ 5.76B |
| $ 36.95B | $ 32.87B | $ 34.68B | $ 37.80B | $ 41.65B | |
| $ 25.92B | $ 25.15B | $ 27.03B | $ 31.17B | $ 36.01B | |
| $ -7.56B | $ 239.91M | $ 875.51M | $ -452.40M | $ -163.21M | |
| $ 18.38B | $ 25.39B | $ 27.91B | $ 30.72B | $ 35.85B | |
| $ 8.78B | $ 21.25B | $ 22.33B | $ 24.31B | $ 28.01B | |
| Per Share Metrics | |||||
| Basic EPS | $ 507.00 | $ 1230.41 | $ 1291.00 | $ 1405.08 | $ 1679.05 |
| Diluted EPS | $ 507.00 | $ 1228.36 | $ 1290.95 | $ 1405.08 | $ 1679.05 |
| Weighted Average Shares Outstanding | 17.77M | 17.30M | 17.30M | 17.30M | 16.68M |
| Weighted Average Shares Outstanding (Diluted) | 17.77M | 17.30M | 17.30M | 17.30M | 16.68M |
Currency in KRW